Most-Upgraded StocksMost-UpgradedNYSE:HUM Humana (HUM) Stock Price, News & Analysis $425.21 -2.17 (-0.51%) Closing price 10/21/2026 03:59 PM EasternExtended Trading$425.28 +0.07 (+0.02%) As of 06:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Humana Stock (NYSE:HUM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Humana alerts:Sign Up Key Stats Today's Range$423.85▼$434.1350-Day Range$371.93▼$432.2452-Week Range$163.11▼$456.50Volume1.48 million shsAverage Volume1.68 million shsMarket Capitalization$51.06 billionP/E Ratio24.85Dividend Yield0.83%Price Target$453.30Consensus RatingModerate Buy Company Overview Humana Inc. is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products. Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings. Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services. The company is headquartered in Louisville, Kentucky. Jim Rechtin serves as Humana’s president and chief executive officer.AI Generated. May Contain Errors. Read More Humana Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreHUM MarketRank™: 4.330261752135 of 5 starsHumana scored higher than 87% of companies evaluated by MarketBeat, and ranked 98th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingModerate Buy Consensus RatingHumana has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 21 buy ratings, 10 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Humana is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageHumana has been the subject of 24 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth77.41% Earnings GrowthEarnings for Humana are expected to grow by 77.41% in the coming year, from $9.03 to $16.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 24.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 24.85, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 213.02.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 2.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.33% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 2.24, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 2.01%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldHumana has a dividend yield of 0.83%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 33.49%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 22.10% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. News and Social Media3.6 / 5News Sentiment0.76 News SentimentHumana has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Humana this week, compared to 10 articles on an average week.Search Interest30 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 329% compared to the previous 30 days.MarketBeat Follows8 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 167% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by Insiders0.20% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HUM Stock News HeadlinesHumana Inc. (HUM) - What Are Researchers Saying About This Stock?3 hours ago | americanbankingnews.comUnitedHealthcare, Humana Medicare Advantage cancellations to affect 1MOctober 21 at 6:31 PM | msn.comDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall. The free download walks through strategies for navigating the options market, but the window to claim it is closing soon.October 22 at 1:00 AM | TradeWins (Ad)The AI Trade Is About to Split in TwoOctober 21 at 5:31 PM | investorplace.com600,000 Humana Medicare Advantage members are losing their plans - here’s what to do if you’re one of themOctober 20 at 2:21 PM | msn.com3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are ShrinkingOctober 19 at 9:14 AM | 247wallst.comHumana Will Drop 37 PPOs for 2027. If Her Plan Is Discontinued, She Can Get a Medigap Window Without Health Questions Even if Humana Offers Another Advantage PlanOctober 15, 2026 | 247wallst.comAmbea Secures Nearly All Humana Shares as Offer Closes and Delisting LoomsOctober 15, 2026 | tipranks.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $256.35 at the beginning of the year. Since then, HUM shares have increased by 65.9% and is now trading at $425.2110. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) posted its quarterly earnings results on Wednesday, July, 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana's revenue for the quarter was up 26.2% compared to the same quarter last year. Read the conference call transcript. Does Humana have any subsidiaries? The following companies are subsidiaries of Humana: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others. Who are Humana's major shareholders? Humana's top institutional shareholders include Assenagon Asset Management S.A. (1.05%), Perpetual Ltd (0.11%), Banque Pictet & Cie SA (0.03%) and Chapin Davis Inc. (0.03%). Insiders that own company stock include Sanjay K Shetty, Timothy S Huval and Jorge S Mesquita. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include NVIDIA (NVDA), UnitedHealth Group (UNH), Visa (V), Salesforce (CRM), Boeing (BA), Netflix (NFLX) and Tesla (TSLA). Company Calendar Record date for 7/31 Dividend6/26/2026Ex-Dividend for 7/31 Dividend6/26/2026Last Earnings7/29/2026Dividend Payable7/31/2026Today10/22/2026Record date for 11/27 Dividend10/30/2026Ex-Dividend for 11/27 Dividend10/30/2026Next Earnings (Estimated)11/06/2026Dividend Payable11/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 HUM's financial health is in the Green zone, according to TradeSmith. HUM has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:HUM CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,060Year Founded1961Price Target and Rating Average Price Target for Humana$453.30 High Price Target$596.00 Low Price Target$195.00 Potential Upside/Downside+6.6%Consensus RatingModerate Buy Rating Score (0-4)2.63 Research Coverage32 Analysts Profitability EPS (Trailing Twelve Months)$10.57 Trailing P/E Ratio24.85 Forward P/E Ratio47.09 P/E Growth2.63Net Income$1.19 billion Net Margins0.88% Pretax Margin1.15% Return on Equity11.20% Return on Assets3.94% Debt Debt-to-Equity Ratio0.62 Current Ratio1.74 Quick Ratio1.74 Sales & Book Value Annual Sales$129.66 billion Price / Sales0.39 Cash Flow$23.94 per share Price / Cash Flow17.76 Book Value$147.47 per share Price / Book2.88Miscellaneous Outstanding Shares120,080,000Free Float119,840,000Market Cap$51.06 billion OptionableOptionable Beta0.74 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:HUM) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
